Search research articles
Contact Us
Filters
Showing results (351-360 of 385) with videos related to
Page
of 39
Sort By:
The New England Journal of Medicine
|
September 23, 2021
Race, Genetic Ancestry, and Estimating Kidney Function in CKD
Chi-Yuan Hsu, Wei Yang, Rishi V Parikh, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 5, 2023
Influence of <i>CYP2C19</i>, <i>CYP2D6</i>, and <i>ABCB1</i> Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study
Farhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report
Nikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
Biological Psychiatry Global Open Science
|
June 12, 2025
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant Depression
Stephen A Murata, Zachary B Madaj, Colt D Capan, et al.
JAMA Psychiatry
|
February 11, 2026
One-Year Actigraphy Study of Sleep and Rest-Activity Rhythms as Markers of Relapse in Depression
Andre C Tonon, Adile Nexha, Jasmyn E A Cunningham, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
March 29, 2025
Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1
Leen Magarbeh, Samar S M Elsheikh, Farhana Islam, et al.
Psychoneuroendocrinology
|
July 6, 2021
Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report
Jee Su Suh, Laura M Fiori, Mohammad Ali, et al.
JAMA Network Open
|
January 4, 2020
Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression
Andrey Zhdanov, Sravya Atluri, Willy Wong, et al.
Kidney International
|
August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group
Carla M Nester, David L Feldman, Richard Burwick, et al.
Elife
|
July 11, 2023
<i>SNORD90</i> induces glutamatergic signaling following treatment with monoaminergic antidepressants
Rixing Lin, Aron Kos, Juan Pablo Lopez, et al.
Page
of 39
Search research articles
Search
Showing results (351-360 of 385) with videos related to
Sort By:
Page
of 39
The New England Journal of Medicine
|
September 23, 2021
Race, Genetic Ancestry, and Estimating Kidney Function in CKD
Chi-Yuan Hsu, Wei Yang, Rishi V Parikh, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 5, 2023
Influence of <i>CYP2C19</i>, <i>CYP2D6</i>, and <i>ABCB1</i> Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study
Farhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report
Nikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
Biological Psychiatry Global Open Science
|
June 12, 2025
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant Depression
Stephen A Murata, Zachary B Madaj, Colt D Capan, et al.
JAMA Psychiatry
|
February 11, 2026
One-Year Actigraphy Study of Sleep and Rest-Activity Rhythms as Markers of Relapse in Depression
Andre C Tonon, Adile Nexha, Jasmyn E A Cunningham, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
March 29, 2025
Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1
Leen Magarbeh, Samar S M Elsheikh, Farhana Islam, et al.
Psychoneuroendocrinology
|
July 6, 2021
Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report
Jee Su Suh, Laura M Fiori, Mohammad Ali, et al.
JAMA Network Open
|
January 4, 2020
Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression
Andrey Zhdanov, Sravya Atluri, Willy Wong, et al.
Kidney International
|
August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group
Carla M Nester, David L Feldman, Richard Burwick, et al.
Elife
|
July 11, 2023
<i>SNORD90</i> induces glutamatergic signaling following treatment with monoaminergic antidepressants
Rixing Lin, Aron Kos, Juan Pablo Lopez, et al.
Page
of 39